Pirker R - Search Results

1

Vinorelbine/gemcitabine in advanced non-small cell lung cancer (NSCLC): a phase I trial.

Krajnik G, Wein W, Greil R, Marhold F, Mohn-Staudner A, Kummer F, Malayeri R, Zöchbauer-Müller S, Huber H, Pirker R. Krajnik G, et al. Among authors: pirker r. Eur J Cancer. 1998 Nov;34(12):1977-80. doi: 10.1016/s0959-8049(98)00235-4. Eur J Cancer. 1998. PMID: 10023326 Clinical Trial.

2

MDR1 gene expression and prognostic factors in primary breast carcinomas.

Wallner J, Depisch D, Hopfner M, Haider K, Spona J, Ludwig H, Pirker R. Wallner J, et al. Among authors: pirker r. Eur J Cancer. 1991;27(11):1352-5. doi: 10.1016/0277-5379(91)90008-2. Eur J Cancer. 1991. PMID: 1835847

3

Effective second line chemotherapy of advanced breast cancer with navelbine and mitomycin C.

Scheithauer W, Kornek G, Haider K, Kwasny W, Schenk T, Pirker R, Depisch D. Scheithauer W, et al. Among authors: pirker r. Breast Cancer Res Treat. 1993;26(1):49-53. doi: 10.1007/BF00682699. Breast Cancer Res Treat. 1993. PMID: 8400323 Clinical Trial.

4

Paclitaxel/cisplatin in advanced non-small-cell lung cancer (NSCLC).

Pirker R, Krajnik G, Zöchbauer S, Malayeri R, Kneussl M, Huber H. Pirker R, et al. Ann Oncol. 1995 Oct;6(8):833-5. doi: 10.1093/oxfordjournals.annonc.a059324. Ann Oncol. 1995. PMID: 8589023 Free article. Clinical Trial.

5

Clinical relevance of drug resistance genes in malignant disease.

Filipits M, Suchomel RW, Zöchbauer S, Malayeri R, Pirker R. Filipits M, et al. Among authors: pirker r. Leukemia. 1996 Jul;10 Suppl 3:S10-S17. Leukemia. 1996. PMID: 8656694 Review.

6

Dexverapamil as resistance modifier in acute myeloid leukaemia.

Pirker R, Zöchbauer S, Kupper H, Lassmann A, Gsur A, Frass M, Krajnik G, Knöbl P, Lechner K. Pirker R, et al. J Cancer Res Clin Oncol. 1995;121 Suppl 3:R21-4. doi: 10.1007/BF02351067. J Cancer Res Clin Oncol. 1995. PMID: 8698738

7

Multidrug resistance in leukemias and its reversal.

Malayeri R, Filipits M, Suchomel RW, Zöchbauer S, Lechner K, Pirker R. Malayeri R, et al. Among authors: pirker r. Leuk Lymphoma. 1996 Nov;23(5-6):451-8. doi: 10.3109/10428199609054853. Leuk Lymphoma. 1996. PMID: 9031075 Review.

8

Delayed anemia and thrombocytopenia after treatment with gemcitabine.

Malayeri R, Krajnik G, Ohler L, Pirker R. Malayeri R, et al. Among authors: pirker r. J Natl Cancer Inst. 1997 Aug 6;89(15):1164. doi: 10.1093/jnci/89.15.1164. J Natl Cancer Inst. 1997. PMID: 9262256 No abstract available.

9

Phase II trial of gemcitabine in advanced non-small-cell lung cancer.

Malayeri R, Ulsperger E, Baumgartner G, Forstner B, Aigner K, Hubner M, Kummer F, Krajnik G, Zöchbauer S, Krejcy K, Huber H, Pirker R. Malayeri R, et al. Among authors: pirker r. Wien Klin Wochenschr. 1997 Sep 19;109(17):688-91. Wien Klin Wochenschr. 1997. PMID: 9331958 Clinical Trial.

10

Neurological monitoring of neurotoxicity induced by paclitaxel/cisplatin chemotherapy.

Berger T, Malayeri R, Doppelbauer A, Krajnik G, Huber H, Auff E, Pirker R. Berger T, et al. Among authors: pirker r. Eur J Cancer. 1997 Aug;33(9):1393-9. doi: 10.1016/s0959-8049(97)00103-2. Eur J Cancer. 1997. PMID: 9337680 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

227 results

Search Page